MENSINGDERMAresearch GmbH

The work at MENSINGDERMAresearch GmbH concentrates on immune system disorders, notably atopic dermatitis and chronic spontaneous urticaria, aiming to test new biologic agents and assess their long‑term safety.

• Novel biologics for skin‑related immune inflammation
• Extended safety monitoring across dose regimens
• Comparative efficacy versus standard care
• Exploration of immune‑pathway biomarkers
• Evaluation of patient‑reported outcome tools

With six active studies and three investigators, the site in Hamburg advances therapeutic options for patients suffering from challenging immune‑mediated skin conditions.

Research at this Hamburg clinic addresses skin and connective tissue diseases such as moderate‑to‑severe plaque psoriasis and various forms of dermatitis, focusing on the development and testing of innovative treatment strategies.

• Targeted therapies for plaque psoriasis
• Dose‑ranging investigations to optimize efficacy
• Biomarker discovery for treatment response
• Real‑world effectiveness and quality‑of‑life assessments
• Combination approaches with existing standards

The centre’s six clinical trials reflect a commitment to improving outcomes for patients with severe skin disorders, leveraging expertise from three dedicated investigators.